The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis
Open accessAbstract
Multiple sclerosis is a common disease of the central nervous system in which the interplay between inflammatory and neurodegenerative processes typically results in intermittent neurological disturbance followed by progressive accumulation of disability. Epidemiological studies have shown that genetic factors are primarily responsible for the substantially increased frequency of the disease seen in the relatives of affected individuals, and systematic attempts to identify linkage in multiplex families have confirmed that variation within the major histocompatibility complex (MHC) exerts the greatest individual effect on risk. Modestly powered genome-wide association studies (GWAS) have enabled more than 20 additional risk loci to be identified and have shown that multiple variants exerting modest individual effects have a key role in disease susceptibility. Most of the genetic architecture underlying susceptibility to the disease remains to be defined and is anticipated to require the analysis of sample sizes that are beyond the numbers currently available to individual research groups. In a collaborative GWAS involving 9,772 cases of European descent collected by 23 research groups working in 15 different countries, we have replicated almost all of the previously suggested associations and identified at least a further 29 novel susceptibility loci. Within the MHC we have refined the identity of the HLA-DRB1 risk alleles and confirmed that variation in the HLA-A gene underlies the independent protective effect attributable to the class I region. Immunologically relevant genes are significantly overrepresented among those mapping close to the identified loci and particularly implicate T-helper-cell differentiation in the pathogenesis of multiple sclerosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The role of the adaptive arm of the immune system, particularly its CD4+ T cell component has become clearer, with multiple different T cell subsets being implicated.(4)”
From Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility (2019) · cites this paper as [4]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“the role of B cells, dendritic cells and natural killer cells has emerged more clearly, broadening the prior narrative of T cell dysregulation that emerged from earlier studies.(4)”
From Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility (2019) · cites this paper as [4]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“published efforts to systematically interrogate severity have, thus far, only involved modest numbers of cases, and unanimously fall short of identifying any convincingly associated genetic variants5,10,11.”
From Locus for severity implicates CNS resilience in progression of multiple sclerosis (2023) · cites this paper as [5]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“refinement of the associations in the HLA region showed that just four variants are sufficient to account for the risk previously attributed to extended haplotype alleles spanning hundreds of kilobases (kb) and many tens of genes.”
From Genome‐wide association studies of multiple sclerosis (2018) · cites this paper as [43]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“the GWAS enrichment studies all point to risk being mediated by gene regulation in CD4+ T cells43”
From Genome‐wide association studies of multiple sclerosis (2018) · cites this paper as [43]
Experimental — accuracy not yet measured
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Several studies have explored the genetic basis of clinical course, age of onset and severity, although no genome‐wide significant associations have been discovered.36, 37, 43, 74, 75, 76, 77”
From Genome‐wide association studies of multiple sclerosis (2018) · cites this paper as [43]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Although these risk variants have been found to reduce the age at onset5, it is notable that they do not appear to have any impact on disease severity6.”
From Locus for severity implicates CNS resilience in progression of multiple sclerosis (2023) · cites this paper as [5]
The cited source says what the claim attributes to it.
In the citing paper
“A further expansion of the IMSGC resulted in a collaborative GWAS of 9772 cases and 17 376 controls, again of European descent, in 2011.43 This study replicated 23 of 26 previously identified associations and identified 29 novel risk loci.”
From Genome‐wide association studies of multiple sclerosis (2018) · cites this paper as [43]
The cited source says what the claim attributes to it.
In the citing paper
“it became evident that these loci are strongly enriched for genes acting in T‐cell activation and proliferation pathways.”
From Genome‐wide association studies of multiple sclerosis (2018) · cites this paper as [43]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gene Ontology: tool for the unification of biology
Ashburner, M., Ball, C. A., Blake, J. A., Botstein, D., Butler, H., Cherry, J. M., Davis, A. P., Dolinski, K., Dwight, S. S., Eppig, J. T., et al. (2000) · Nature Genetics · doi:10.1038/75556 · Cited by 43,206
Compston, A., & Coles, A. J. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61620-7 · Cited by 4,699
Genomic Control for Association Studies
Devlin, B., & Roeder, K. (1999) · Biometrics · doi:10.1111/j.0006-341x.1999.00997.x · Cited by 3,162 · cited 1×
“However, even use of all seven top principal components that captured genome-wide effects in our data resulted in an unacceptably high genomic inflation: for example, the genomic control facto”
Variance component model to account for sample structure in genome-wide association studies
Kang, H. M., Sul, J. H., Service, S. K., Zaitlen, N. A., Kong, S.-Y., Freimer, N. B., Sabatti, C., & Eskin, E. (2010) · Nature Genetics · doi:10.1038/ng.548 · Cited by 2,817
Risk Alleles for Multiple Sclerosis Identified by a Genomewide Study
(2007) · New England Journal of Medicine · doi:10.1056/nejmoa073493 · Cited by 1,746
Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants
Wellcome Trust Case Control Consortium, & The Australo-Anglo-American Spondylitis Consortium (TASC) (2007) · Nature Genetics · doi:10.1038/ng.2007.17 · Cited by 1,374
Strange, A., Spencer, C. C. A., Band, G., Bellenguez, C., Freeman, C., Pirinen, M., Rautanen, A., Su, Z., Donnelly, P., Capon, F., et al. (2010) · Nature Genetics · doi:10.1038/ng.694 · Cited by 1,056
International MS Genetics Consortium, De Jager, P. L., Jia, X., Wang, J., de Bakker, P. I. W., Ottoboni, L., Aggarwal, N. T., Piccio, L., Raychaudhuri, S., Tran, D., et al. (2009) · Nature Genetics · doi:10.1038/ng.401 · Cited by 800
The Australia and New Zealand Multiple Sclerosis Genetics Consortium (ANZgene) (2009) · Nature Genetics · doi:10.1038/ng.396 · Cited by 550
Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis
Baranzini, S. E., Wang, J., Gibson, R. A., Galwey, N., Naegelin, Y., Barkhof, F., Radue, E.-W., Lindberg, R. L. P., Uitdehaag, B. M. G., Johnson, M. R., et al. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddn388 · Cited by 476
Cited by
Sorted by citations
Items 801–900 of 1,003
Overexpression of Kinesin Superfamily Motor Proteins in Alzheimer’s Disease
Hares, K. M., Miners, J. S., Cook, A. J., Rice, C. M., Scolding, N. J., Love, S., & Wilkins, A. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170094 · Cited by 42
Role of diet in regulating the gut microbiota and multiple sclerosis
Sanchez, J. M. S., DePaula-Silva, A. B., Libbey, J. E., & Fujinami, R. S. (2020) · Clinical Immunology · doi:10.1016/j.clim.2020.108379 · Cited by 42
Menegatti, J., Schub, D., Schäfer, M., Grässer, F. A., & Ruprecht, K. (2021) · European Journal of Immunology · doi:10.1002/eji.202149179 · Cited by 42
Hess, J. L., Akutagava-Martins, G. C., Patak, J. D., Glatt, S. J., & Faraone, S. V. (2018) · Molecular Psychiatry · doi:10.1038/mp.2017.242 · Cited by 42
The IL-2 – IL-2 receptor pathway: Key to understanding multiple sclerosis
Peerlings, D. E. M., Mimpen, M., & Damoiseaux, J. G. M. C. (2021) · Journal of Translational Autoimmunity · doi:10.1016/j.jtauto.2021.100123 · Cited by 45
Bach2: A Key Regulator in Th2-Related Immune Cells and Th2 Immune Response
Liu, G., & Liu, F. (2022) · Journal of Immunology Research · doi:10.1155/2022/2814510 · Cited by 41
Shahijanian, F., Parnell, G. P., McKay, F. C., Gatt, P. N., Shojoei, M., O'Connor, K. S., Schibeci, S. D., Brilot, F., Liddle, C., Batten, M., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt529 · Cited by 41
Immunologic profiles of multiple sclerosis treatments reveal shared early B cell alterations
Dooley, J., Pauwels, I., Franckaert, D., Smets, I., Garcia‐Perez, J. E., Hilven, K., Danso‐Abeam, D., Terbeek, J., Nguyen, A. T. L., Muynck, L. D., et al. (2016) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000240 · Cited by 41
Abdollahzadeh, R., Fard, M. S., Rahmani, F., Moloudi, K., Kalani, B. S., & Azarnezhad, A. (2016) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2016.05.053 · Cited by 41
Pan, G., Simpson, S., van der Mei, I. A. F., Charlesworth, J., Lucas, R. M., Ponsonby, A., Zhou, Y., Wu, F., & Taylor, B. V. (2016) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2016-313722 · Cited by 41
Klasić, M., Markulin, D., Vojta, A., Samaržija, I., Biruš, I., Dobrinić, P., Ventham, N. T., Trbojević‐Akmačić, I., Šimurina, M., Štambuk, J., et al. (2018) · Clinical Epigenetics · doi:10.1186/s13148-018-0507-y · Cited by 41
Common variation near IRF6 is associated with IFN-β-induced liver injury in multiple sclerosis
Kowalec, K., Wright, G. E. B., Drögemöller, B. I., Aminkeng, F., Bhavsar, A. P., Kingwell, E., Yoshida, E. M., Traboulsee, A. L., Marrie, R. A., Kremenchutzky, M., et al. (2018) · Nature Genetics · doi:10.1038/s41588-018-0168-y · Cited by 41
Pharmacological inhibition of GPR4 remediates intestinal inflammation in a mouse colitis model
Sanderlin, E. J., Marie, M. A., Velcicky, J., Loetscher, P., & Yang, L. V. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.03.038 · Cited by 41
Kwiatkowski, A. J., Stewart, J. M., Cho, J. J., Avram, D., & Keselowsky, B. G. (2020) · Advanced Healthcare Materials · doi:10.1002/adhm.202000164 · Cited by 43
The influence of HLA‐DRB1*15 on motor cortical pathology in multiple sclerosis
Yates, R. L., Esiri, M. M., Palace, J. A., Mittal, A., & DeLuca, G. C. (2014) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12165 · Cited by 41
Chabod, M., Pedros, C., Lamouroux, L., Colacios, C., Bernard, I., Lagrange, D., Balz-Hara, D., Mosnier, J., LABOISSE, C. L., Vergnolle, N., et al. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002461 · Cited by 45
Sousa, A. D. P. A., Malmegrim, K. C. R., Panepucci, R. A., Brum, D. G., Barreira, A. A., dos Santos, A. C., Araújo, A. G., Covas, D. T., Oliveira, M. C., Moraes, D. A., et al. (2014) · Clinical Science · doi:10.1042/cs20140095 · Cited by 41
Rostgaard, K., Wohlfahrt, J., & Hjalgrim, H. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu204 · Cited by 41
Thomas, O. G., Rickinson, A. B., & Palendira, U. (2023) · Clinical & Translational Immunology · doi:10.1002/cti2.1451 · Cited by 40
Cholesterol in the CNS: functions, recycling and remyelination
Wuerch, E. C., & Yong, V. W. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03490-8 · Cited by 41
Anoctamin-2-specific T cells link Epstein-Barr virus to multiple sclerosis
Thomas, O. G., Rykaczewska, U., Galesic, M., van der Burgt, R. T. M., Hallen, N., Ferro, F., Bronge, M., Marti, Z., Li, Y., Rique, A. H., et al. (2026) · Cell · doi:10.1016/j.cell.2025.12.032 · Cited by 41
Endocannabinoids in Multiple Sclerosis and Amyotrophic Lateral Sclerosis
Pryce, G., & Baker, D. (2015) · Handbook of experimental pharmacology · doi:10.1007/978-3-319-20825-1_7 · Cited by 40
Vitamin D, Immune Tolerance, and Prevention of Type 1 Diabetes
Badenhoop, K. W. J., Kahles, H., & Penna-Martinez, M. (2012) · Current Diabetes Reports · doi:10.1007/s11892-012-0322-3 · Cited by 40
Leikfoss, I. S., Mero, I.-L., Dahle, M. K., Lie, B. A., Harbo, H. F., Spurkland, A., & Berge, T. (2012) · Genes and Immunity · doi:10.1038/gene.2012.52 · Cited by 40
Th1 not Th17 cells drive spontaneous MS-like disease despite a functional regulatory T cell response
Lowther, D. E., Chong, D. L. W., Ascough, S., Ettorre, A., Ingram, R. J., Boyton, R. J., & Altmann, D. M. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1159-9 · Cited by 40
Genome-wide significant association with seven novel multiple sclerosis risk loci
Lill, C. M., Luessi, F., Alcina, A., Sokolova, E. А., Ugidos-Damboriena, N., de la Hera, B., Guillot‐Noël, L., Malhotra, S., Reinthaler, E. M., Schjeide, B. M., et al. (2015) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2015-103442 · Cited by 43
Liu, Y., Gibson, S. A., Benveniste, E. N., & Qin, H. (2015) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.2016015517 · Cited by 43
Ulges, A., Witsch, E., Pramanik, G. K., Klein, M., Birkner, K., Bühler, U., Wasser, B., Luessi, F., Stergiou, N., Dietzen, S., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1523869113 · Cited by 42
Inshaw, J. R. J., Walker, N. M., Wallace, C., Bottolo, L., & Todd, J. A. (2017) · Diabetologia · doi:10.1007/s00125-017-4440-y · Cited by 41
The Genetics of Multiple Sclerosis
Didonna, A., & Oksenberg, J. R. (2017) · Codon Publications eBooks · doi:10.15586/codon.multiplesclerosis.2017.ch1 · Cited by 44
Neuronal methylome reveals CREB-associated neuro-axonal impairment in multiple sclerosis
Kular, L., Needhamsen, M., Adzemovic, M. Z., Kramarova, T. V., Gómez-Cabrero, D., Ewing, E., Piket, E., Tegner, J. N., Beck, S., Piehl, F., et al. (2019) · Clinical Epigenetics · doi:10.1186/s13148-019-0678-1 · Cited by 42
McGowan, L. M., Smith, G. D., Gaunt, T. R., & Richardson, T. G. (2019) · Human Molecular Genetics · doi:10.1093/hmg/ddz155 · Cited by 40
Update on the pathogenesis and management of ocular rosacea: an interdisciplinary review
Jabbehdari, S., Memar, O. M., Caughlin, B., & Djalilian, A. R. (2020) · European Journal of Ophthalmology · doi:10.1177/1120672120937252 · Cited by 40
State-of-the-art genome inference in the human MHC
Dilthey, A. (2020) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2020.105882 · Cited by 42
Jin, T., Rehani, P. R., Ying, M., Huang, J., Liu, S., Roussos, P., & Wang, D. (2021) · Genome Medicine · doi:10.1186/s13073-021-00908-9 · Cited by 42
New Multiple Sclerosis Disease Severity Scale Predicts Future Accumulation of Disability
Weideman, A. M., Barbour, C. R., Tapia-Maltos, M. A., Tran, T., Jackson, K. C., Kosa, P. F., Komori, M., Wichman, A., Johnson, K. R., Greenwood, M., et al. (2017) · Frontiers in Neurology · doi:10.3389/fneur.2017.00598 · Cited by 40
Dissecting shared genetic architecture between obesity and multiple sclerosis
Zeng, R., Jiang, R., Huang, W., Wang, J., Zhang, L., Ma, Y., Wu, Y., Meng, M., Lan, H., Lian, Q., et al. (2023) · EBioMedicine · doi:10.1016/j.ebiom.2023.104647 · Cited by 41
Chitnis, T., Qureshi, F., Gehman, V. M., Becich, M. J., Bove, R. M., Cree, B., Gomez, R., Hauser, S. L., Henry, R. G., Katrib, A., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-48602-9 · Cited by 39
The dual nature of neuroinflammation in networked brain
Müller, L., Benedetto, S. D., & Müller, V. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1659947 · Cited by 43
Payne, N. L., Sylvain, A., O’Brien, C., Herszfeld, D., Sun, G., & Bernard, C. C. A. (2014) · New Biotechnology · doi:10.1016/j.nbt.2014.05.001 · Cited by 41
D'hooghe, M. B., D’Hooghe, T., & Keyser, J. D. (2013) · Gynecologic and Obstetric Investigation · doi:10.1159/000346319 · Cited by 40
CXCR5 polymorphisms in non-Hodgkin lymphoma risk and prognosis
Charbonneau, B., Wang, A. H., Maurer, M. J., Asmann, Y. W., Zent, C. S., Link, B. K., Ansell, S. M., Weiner, G. J., Özsan, N., Feldman, A. L., et al. (2013) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-013-1452-4 · Cited by 39
Remote control — triggering of brain autoimmune disease in the gut
Wekerle, H., Berer, K., & Krishnamoorthy, G. (2013) · Current Opinion in Immunology · doi:10.1016/j.coi.2013.09.009 · Cited by 39
Strange, A., Bellenguez, C., Sim, X., Luben, R., Hysi, P. G., Ramdas, W. D., van Koolwijk, L. M. E., Freeman, C., Pirinen, M., Su, Z., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt293 · Cited by 39
Case, L. K., Wall, E. H., Osmanski, E., Dragon, J. A., Saligrama, N., Zachary, J. F., Lemos, B., Blankenhorn, E. P., & Teuscher, C. (2015) · Genome biology · doi:10.1186/s13059-015-0591-7 · Cited by 39
Nakamura, Y., Matsushita, T., Sato, S., Niino, M., Fukazawa, T., Yoshimura, S., Hisahara, S., Isobe, N., Shimohama, S., Watanabe, M., et al. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0695-3 · Cited by 39
Cbl-b Deficiency Mediates Resistance to Programed Death-Ligand 1/Programed Death-1 Regulation
Fujiwara, M., Anstadt, E. J., & Clark, R. B. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00042 · Cited by 39
Ramasamy, R., Joseph, B., & Whittall, T. (2017) · Immunology Letters · doi:10.1016/j.imlet.2017.02.003 · Cited by 39
Ramstetter, M. D., Shenoy, S. A., Dyer, T. D., Lehman, D. M., Curran, J. E., Duggirala, R., Blangero, J., Mezey, J. G., & Williams, A. L. (2018) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2018.05.008 · Cited by 40
Genetic overlap between autoimmune diseases and non‐Hodgkin lymphoma subtypes
Din, L., Sheikh, M., Kosaraju, N., Smedby, K. E. E., Bernatsky, S., Berndt, S. I., Skibola, C. F., Nieters, A., WANG, S. S., McKay, J., et al. (2019) · Genetic Epidemiology · doi:10.1002/gepi.22242 · Cited by 39
Multiple sclerosis risk variants regulate gene expression in innate and adaptive immune cells
Gresle, M. M., Jordan, M. A., Stankovich, J. M., Spelman, T. D., Johnson, L., Laverick, L., Hamlett, A., Smith, L. D., Jokubaitis, V., Baker, J., et al. (2020) · Life Science Alliance · doi:10.26508/lsa.202000650 · Cited by 40
Watanabe, M., Nakamura, Y., Sato, S., Niino, M., Fukaura, H., Tanaka, M., Ochi, H., Kanda, T., Takeshita, Y., Yokota, T., et al. (2021) · Scientific Reports · doi:10.1038/s41598-020-79833-7 · Cited by 39
Mechanisms of demyelination and neurodegeneration in globoid cell leukodystrophy
Feltri, M. L., Weinstock, N. I., Favret, J., Dhimal, N., Wrabetz, L. G., & Shin, D. (2021) · Glia · doi:10.1002/glia.24008 · Cited by 39
Multiple Sclerosis and the Blood-Central Nervous System Barrier
Palmer, A. M. (2013) · Cardiovascular Psychiatry and Neurology · doi:10.1155/2013/530356 · Cited by 40
Gender and Uveitis in Patients with Multiple Sclerosis
Gordon, L. K., & Goldstein, D. A. (2014) · Journal of Ophthalmology · doi:10.1155/2014/565262 · Cited by 39
Roshanisefat, H., Bahmanyar, S., Hillert, J. A., Olsson, T. P., & Montgomery, S. (2012) · Multiple Sclerosis Journal · doi:10.1177/1352458512438240 · Cited by 39
Castelo‐Branco, G., Stridh, P., Guerreiro‐Cacais, A. O., Adzemovic, M. Z., Falcão, A. M., Marta, M., Berglund, R., Gillett, A., Hamza, K. H., Lassmann, H., et al. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.08.019 · Cited by 39
Body mass index as a predictor of MS activity and progression among participants in BENEFIT
Manuel Escobar, J., Cortese, M., Edan, G., Freedman, M. S., Hartung, H.-P., Montalbán, X., Sandbrink, R., Radü, E.-W., Barkhof, F., Wicklein, E.-M., et al. (2022) · Multiple Sclerosis Journal · doi:10.1177/13524585211061861 · Cited by 38
Mathieu, S., Briend, M., Abner, E., Couture, C. Y., Li, Z., Bossé, Y., Thériault, S., Esko, T., Arsenault, B. J., & Mathieu, P. (2022) · iScience · doi:10.1016/j.isci.2022.104992 · Cited by 38
The genetic history of Scandinavia from the Roman Iron Age to the present
Varela, R., Moore, K. H. S., Ebenesersdóttir, S. S., Kılınç, G. M., Kjellström, A., Papmehl-Dufay, L., Alfsdotter, C., Berglund, B., Alrawi, L., Kashuba, N., et al. (2023) · Cell · doi:10.1016/j.cell.2022.11.024 · Cited by 40
Epistasis and immunity: the role of genetic interactions in autoimmune diseases
Rose, A. M., & Bell, L. C. K. (2012) · Immunology · doi:10.1111/j.1365-2567.2012.03623.x · Cited by 40
Genetic burden in multiple sclerosis families
Isobe, N., Damotte, V., Re, V. L., Ban, M., Pappas, D. J., Guillot‐Noël, L., Cournu‐Rebeix, I., Compston, A., Mack, T. M., Cozen, W., et al. (2013) · Genes and Immunity · doi:10.1038/gene.2013.37 · Cited by 38
Genetic variants in IL2RA and IL7R affect multiple sclerosis disease risk and progression
Traboulsee, A. L., Bernales, C. Q., Ross, J. P., Lee, J. D., Sadovnick, A. D., & Vilariño‐Güell, C. (2014) · Neurogenetics · doi:10.1007/s10048-014-0403-3 · Cited by 41
Jin, Y., Sharma, A. K., Bai, S., Davis, C., Liu, H., Hopkins, D., Barriga, K., Rewers, M., & She, J. (2014) · Diabetes · doi:10.2337/db13-1716 · Cited by 39
Wangler, M. F., Hu, Y., & Shulman, J. M. (2017) · Disease Models & Mechanisms · doi:10.1242/dmm.027680 · Cited by 41
Genomic insights into the population structure and history of the Irish Travellers
Gilbert, E. H., Carmi, S., Ennis, S., Wilson, J. F., & Cavalleri, G. L. (2017) · Scientific Reports · doi:10.1038/srep42187 · Cited by 45
Scholz, E., Marcilla, M., Daura, X., Arribas-Layton, D., James, E. A., & Álvarez, I. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00984 · Cited by 38
Kunkl, M., Sambucci, M., Ruggieri, S., Amormino, C., Tortorella, C., Gasperini, C., Battistini, L., & Tuosto, L. (2019) · Cells · doi:10.3390/cells8060575 · Cited by 39
Hardwick, S. A., Bassett, S. D., Kaczorowski, D. C., Blackburn, J., Barton, K., Bartoniček, N., Carswell, S., Tilgner, H., Loy, C. T., Halliday, G. M., et al. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00309 · Cited by 41
Environmental Influencers, MicroRNA, and Multiple Sclerosis
Mohammed, E. M. A. (2020) · Journal of Central Nervous System Disease · doi:10.1177/1179573519894955 · Cited by 39
Encephalitogenic and Regulatory CD8 T Cells in Multiple Sclerosis and Its Animal Models
Mockus, T. E., Munie, A. N., Atkinson, J., & Segal, B. M. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.2000797 · Cited by 38
HLA-DRB1-DQB1 Haplotypes Confer Susceptibility and Resistance to Multiple Sclerosis in Sardinia
Cocco, E. E., Sardu, C., Pieroni, E., Valentini, M. C., Murru, R., Costa, G., Tranquilli, S., Frau, J., Coghe, G., Carboni, N., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033972 · Cited by 38
Genetic variants related to gap junctions and hormone secretion influence conception rates in cows
Sugimoto, M., Sasaki, S., GOTOH, Y., Nakamura, Y., Aoyagi, Y., Kawahara, T., & Sugimoto, Y. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1309307110 · Cited by 38
Paraboschi, E. M., Rimoldi, V., Soldà, G., Tabaglio, T., Dall’Osso, C., Saba, E., Vigliano, M., Salviati, A., Leone, M. A., Benedetti, M. D., et al. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu392 · Cited by 38
HLA ‐alleles associated with increased risk for extra‐pulmonary involvement in sarcoidosis
Darlington, P., Gabrielsen, A., Sörensson, P., Tallstedt, L., Padyukov, L., Eklúnd, A., & Grünewald, J. (2014) · Tissue Antigens · doi:10.1111/tan.12326 · Cited by 38
The autoimmunity-associated gene RGS1 affects the frequency of T follicular helper cells
Caballero‐Franco, C., & Kissler, S. (2016) · Genes and Immunity · doi:10.1038/gene.2016.16 · Cited by 39
The Irish DNA Atlas: Revealing Fine-Scale Population Structure and History within Ireland
Gilbert, E. H., O’Reilly, S., Merrigan, M., McGettigan, D., Molloy, A. M., Brody, L. C., Bodmer, W. F., Hutnik, K., Ennis, S., Lawson, D. J., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-17124-4 · Cited by 40
Imitola, J., Rasouli, J., Watanabe, F., Mahajan, K., Sharan, A. D., Ćirić, B., Zhang, G., & Rostami, A. M. (2017) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2017.12.017 · Cited by 38
Long-read sequencing for 29 immune cell subsets reveals disease-linked isoforms
Inamo, J., Suzuki, A., Ueda, M. T., Yamaguchi, K., Nishida, H., Suzuki, K., Kaneko, Y., Takeuchi, T., Hatano, H., Ishigaki, K., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-48615-4 · Cited by 37
Mucosal-Associated Invariant T Cells in Multiple Sclerosis: The Jury is Still Out
Treiner, E., & Liblau, R. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00503 · Cited by 37
Genetics of multiple sclerosis
Hoppenbrouwers, I. A., & Hintzen, R. Q. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.09.017 · Cited by 39
THEMIS: a critical TCR signal regulator for ligand discrimination
Gascoigne, N. R. J., & Acuto, O. (2015) · Current Opinion in Immunology · doi:10.1016/j.coi.2015.01.020 · Cited by 37
ALCAM and CD6 — multiple sclerosis risk factors
Wagner, M., Bilińska, M. M., Pokryszko‐Dragan, A., Sobczyński, M., Cyrul, M., Kuśnierczyk, P., & Jasek, M. (2014) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2014.08.621 · Cited by 37
Speed, D., Hoggart, C., Petrovski, S., Tachmazidou, I., Coffey, A. J., Jorgensen, A., Eleftherohorinou, H., Iorio, M. D., Todaro, M., De, T., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt403 · Cited by 37
Regulation of Experimental Autoimmune Encephalomyelitis by TPL-2 Kinase
Sriskantharajah, S., Gückel, E., Tsakiri, N., Kierdorf, K., Brender, C., Ben-Addi, A., Veldhoen, M., Tsichlis, P. N., Stockinger, B., O’Garra, A., et al. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1300172 · Cited by 37
A Complex Role of Herpes Viruses in the Disease Process of Multiple Sclerosis
Wuest, S. C., Mexhitaj, I., Chai, N. R., Romm, E., Scheffel, J., Xu, B., Lane, K. C., Wu, T., & Bielekova, B. (2014) · PLoS ONE · doi:10.1371/journal.pone.0105434 · Cited by 37
Honne, K., Hallgrímsdóttir, I. B., Wu, C. S., Sebro, R., Jewell, N. P., Sakurai, T., Iwamoto, M., Minota, S., & Jawaheer, D. (2016) · Arthritis Research & Therapy · doi:10.1186/s13075-016-0920-6 · Cited by 37
Preferential Use of Public TCR during Autoimmune Encephalomyelitis
Zhao, Y., Nguyen, P., Ma, J., Wu, T., Jones, L. L., Pei, D., Cheng, C., & Geiger, T. L. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1501029 · Cited by 37
Hossain, M. J., Tănăsescu, R., & Gran, B. (2016) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2016.12.004 · Cited by 37
Nogo-A Antibodies for Progressive Multiple Sclerosis
Ineichen, B. V., Plattner, P. S., Good, N., Martinꝉ, R., Linnebank, M., & Schwab, M. E. (2017) · CNS Drugs · doi:10.1007/s40263-017-0407-2 · Cited by 37
Association of Pre-Disease Body Mass Index With Multiple Sclerosis Prognosis
Manouchehrinia, A., Hedström, A. K., Alfredsson, L. S., Olsson, T. P., Hillert, J. A., & Ramanujam, R. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00232 · Cited by 37
Petersen, E. R., Søndergaard, H. B., Laursen, J. H., Olsson, A., Börnsen, L. S., Sørensen, P. S., Sellebjerg, F. T., & Oturai, A. B. (2018) · Multiple Sclerosis Journal · doi:10.1177/1352458518791753 · Cited by 37
Cloake, N. C., Yan, J., Aminian, A., Pender, M. P., & Greer, J. M. (2018) · Journal of Clinical Medicine · doi:10.3390/jcm7100342 · Cited by 37
Interpreting Non-coding Genetic Variation in Multiple Sclerosis Genome-Wide Associated Regions
Paraboschi, E. M., Cardamone, G., Soldà, G., Duga, S., & Asselta, R. (2018) · Frontiers in Genetics · doi:10.3389/fgene.2018.00647 · Cited by 37
Pytel, V., Matías‐Guiu, J. A., Torre‐Fuentes, L., Montero‐Escribano, P., Maietta, P., Botet, J., Álvarez, S., Gómez‐Pinedo, U., & Matías‐Guiu, J. (2019) · Brain and Behavior · doi:10.1002/brb3.1272 · Cited by 37
Genetic model of MS severity predicts future accumulation of disability
Jackson, K. C., Sun, K., Barbour, C. R., Hernandez, D. G., Kosa, P. F., Tanigawa, M., Weideman, A. M., & Bielekova, B. (2019) · Annals of Human Genetics · doi:10.1111/ahg.12342 · Cited by 37
Zhao, Y., Lv, J., Zhang, H., Xie, J., Zhang, X., & Hui, D. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.665442 · Cited by 37
Wang, S., Chen, H., Wen, X., Mu, J., Sun, M., Song, X., Liu, B., Chen, J., & Fan, X. (2021) · Journal of Immunology Research · doi:10.1155/2021/4400428 · Cited by 37
A Quantitative Synthesis of Eight Decades of Global Multiple Sclerosis Research Using Bibliometrics
Ismail, I. I., & Saqr, M. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.845539 · Cited by 39
Current and Future Therapies Targeting the Immune System in Multiple Sclerosis
Loleit, V., Biberacher, V., & Hemmer, B. (2014) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201015666140617104332 · Cited by 37
Metadata
- Authors
- The International Multiple Sclerosis Genetics Consortium & The Wellcome Trust Case Control Consortium 2
- Venue
- Nature
- Published
- 2011-08
- Volume
- 476
- Issue
- 7359
- Pages
- 214-219
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC3182531
- OpenAlex
- W2040547343
- Cited by
- 2,697
- References
- 26
- Citations by year
- 2026: 72 · 2025: 101 · 2024: 112 · 2023: 111 · 2022: 136 · 2021: 155 · 2020: 167 · 2019: 173 · 2018: 178 · 2017: 215 · 2016: 220 · 2015: 273 · 2014: 244 · 2013: 279 · 2012: 223
- FWCI
- 175.77
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Discovery Research Portal (University of Dundee) (publishedVersion)
- Zurich Open Repository and Archive (University of Zurich) (acceptedVersion, other-oa)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
- Keele Research Repository (Keele University) (submittedVersion, cc-by)
- PEARL (University of Plymouth) (submittedVersion)
- eCite Digital Repository (University of Tasmania) (submittedVersion)
- UWA Profiles and Research Repository (UWA) (submittedVersion)
- Murdoch University Research Portal (submittedVersion)
- Arrow@dit (Dublin Institute of Technology) (submittedVersion, cc-by-nc-sa)
- HAL (submittedVersion)
- MDC Repository (Max-Delbrueck-Center for Molecular Medicine) (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Figshare (submittedVersion)
- IRIS Research product catalog (Sapienza University of Rome) (submittedVersion)
- Archivio Istituzionale della Ricerca - Università Vita-Salute San Raffaele (submittedVersion)
- Minerva Access (University of Melbourne) (submittedVersion)
- Research Portal (King's College London) (submittedVersion)
- mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich) (submittedVersion)
- Site cant be reached (submittedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
- Research Explorer (The University of Manchester) (submittedVersion)
- Griffith Research Online (submittedVersion)
- VUBIR (Vrije Universiteit Brussel) (submittedVersion)
- STM:n Hallinnonalan avoin julkaisuarkisto (Julkari) (submittedVersion)
- Zurich Open Repository and Archive (University of Zurich) (submittedVersion, other-oa)
- Faculty of Health; Institute of Health and Biomedical Innovation
- Zurich Open Repository and Archive (University of Zurich)
- Funders
- Susan G. Komen for the Cure
- Biogen
- Kaiser Permanente
- Children's Hospital of Philadelphia
- Fondazione CRT
- Fondation pour l'Aide à la Recherche sur la Sclérose en Plaques
- Institute of Clinical and Translational Sciences
- Scleroseforeningen
- Helsingin ja Uudenmaan Sairaanhoitopiiri
- Wellcome Trust (085475/Z/08/Z, 068545/Z/02), 085475, G0000934, 075491, 068545, 075491/Z/04,, 090532, 085475/B/08/Z, 084702)
- National Institute for Health and Care Research (G0000934, NF-SI-0507-10379, PDA/02/06/016)
- Parkinson's UK (G0909, J‐0804)
- Multiple Sclerosis Society (898/08)
- Multiple Sclerosis Australia
- Deutsche Forschungsgemeinschaft
- Agence Nationale de la Recherche (ANR-10-INBS-0001)
- Institut National de la Santé et de la Recherche Médicale
- Forskningsrådet för Arbetsliv och Socialvetenskap
- Academy of Finland
- Fonds Wetenschappelijk Onderzoek
- Ministero della Salute (502/92, D.lgs 502/92)
- Hjärnfonden
- Knut och Alice Wallenbergs Stiftelse
- Stockholms Läns Landsting (562183)
- Norges Forskningsråd
- Regione Piemonte (502/92)
- Haukeland Universitetssjukehus
- Vlaamse regering
- National Institutes of Health (5r01ns019142-03, G0000934, 075491/Z/04, 068545/Z/02, UL1TR000448, NS43559, NS19142, RR024992, CA104021, NS049477)
- U.S. Public Health Service (K23N/S048869)
- Medical Research Council (MC_EX_G0800860, 068545/Z/02, G0000934)
- National Health and Medical Research Council (G0000934)
- Helmholtz Zentrum München
- National Cancer Institute (R01CA104021, CA104021)
- National Institute of Allergy and Infectious Diseases (AI076544, R01AI076544)
- Fogarty International Center (K01TW009996)
- National Institute of Neurological Disorders and Stroke (NS067305, NS26799, NS 43559, NS032830, NS049477, NS19142, R01NS032830, R01NS043559, R01NS026799, R01NS049510, R01NS067305, NS049510, R01NS049477)
- National Center for Research Resources (RR020092, C06RR020092, RR-024992, UL1RR024992)
- National Center for Advancing Translational Sciences
- Topics
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Keywords
- multiple sclerosis, genetic susceptibility, genome-wide association study, major histocompatibility complex, T helper cell differentiation, cell-mediated immunity, neuroinflammation, neurodegeneration, pathogenesis, genetic susceptibility loci
- MeSH terms
- Alleles, Cell Differentiation, Europe, T-Lymphocytes, Helper-Inducer, HLA-DR Antigens, Humans, Immunity, Cellular, Major Histocompatibility Complex, Multiple Sclerosis, HLA-A Antigens, Genome, Human, Sample Size, Genetic Predisposition to Disease, Polymorphism, Single Nucleotide, Genome-Wide Association Study, HLA-DRB1 Chains
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
